Cynata Therapeutics | LinkedIn (original) (raw)
``
Biotechnology Research
Cremorne, Victoria 3,679 followers
A Next Generation Stem Cell Therapeutics Company
About us
Cynata Therapeutics Limited (ASX: CYP) is an Australian clinical-stage stem cell and regenerative medicine company focused on the development of therapies based on Cymerus™, a proprietary therapeutic stem cell platform technology. Cymerus™ overcomes the challenges of other production methods by using induced pluripotent stem cells (iPSCs) and a precursor cell known as mesenchymoangioblast (MCA) to achieve economic manufacture of cell therapy products, including mesenchymal stem cells (MSCs), at commercial scale without the limitation of multiple donors. Cynata’s lead product candidate CYP-001 met all clinical endpoints and demonstrated positive safety and efficacy data for the treatment of steroid-resistant acute graft-versus-host disease (GvHD) in a Phase 1 trial. Clinical trials of Cymerus MSC products in osteoarthritis (Phase 3) and in severe complications arising from COVID-19 (Phase 2) are currently ongoing. Planning is also underway for further clinical trials of Cymerus MSC products in GvHD (through licensee Fujifilm), critical limb ischemia, idiopathic pulmonary fibrosis, renal transplantation, and diabetic foot ulcers. In addition, Cynata has demonstrated utility of its Cymerus MSC technology in preclinical models of numerous diseases, including the clinical targets mentioned above, as well as asthma, heart attack, sepsis, acute respiratory distress syndrome (ARDS) and cytokine release syndrome.
Industry
Biotechnology Research
Company size
2-10 employees
Headquarters
Cremorne, Victoria
Type
Public Company
Specialties
Stem cells, MSCs, and iPSCs
Locations
Employees at Cynata Therapeutics
Updates
- 📅 Join us for our upcoming investor webinar on Thursday, 5 September at 9:30am. CEO & Managing Director Dr Kilian Kelly will be presenting alongside Chief Business Officer Dr Mathias Kroll. This is your chance to hear the latest updates re clinical trial milestones and partnering strategy, and ask your questions. Register here to reserve your spot: https://bit.ly/3Z941aL #biotech #investor #webinar #ASX
- Dr Kilian Kelly updates Proactive on Cynata following his presentation at the Bioshares Biotech Summit
Cynata Therapeutics Ltd (ASX:CYP) CEO and managing director Dr Kilian Kelly is in the Proactive studio following the 18th annual #BiosharesBiotechSummit in Perth. Cynata is an Australian #StemCell and #RegenerativeMedicine company that is developing a therapeutic stem cell platform technology, Cymerus™, using discoveries made at the University of Wisconsin-Madison (UWM). UWM is a world-renowned leader in stem cell research, in particular for the work by Professor James Thomson’s group, which included the first successful isolation of human embryonic stem cells in 1998 and the derivation of induced pluripotent stem cells (iPSCs) from human adult cells in 2007. Professor Igor Slukvin, a co-founder of Cynata, was also a member of the team that conducted UWM’s pioneering iPSC research. Watch at #Proactive #ProactiveInvestors #Biotech #Biopharmaceutcials https://lnkd.in/e3z7hFE8
Cynata Therapeutics talks 18th annual Bioshares Biotech Summit
https://www.youtube.com/
- Cynata will acquire the groundbreaking wound dressing technology developed by TekCyte Limited. This innovative technology is a key component of our Cymerus™ iPSC-derived MSC topical wound dressing product candidate, CYP-006TK, currently undergoing a Phase 1 clinical trial for diabetic foot ulcers. Read today’s announcement here: https://bit.ly/3IhTz71 #stemcells #innovation #diabetes #woundtreatment # #newsalert
- Watch our webinar with Cynata Therapeutics, featuring Managing Director and CEO Dr. Kilian Kelly. The webinar will commence with a presentation, followed by a live Q&A with the audience, providing you the opportunity to ask Kilian any questions about CYP that you may have. Key topics: - Cynata's unique proposition compared to other stem cell products on the market - Cynata’s aGVHD trial and the publication in Nature Medicine - Strategy for commercial partnerships Register here: https://hubs.ly/Q02CXfRB0 #asx #shares #stocks
- Register now for an exclusive Sharewise webinar featuring Managing Director and CEO Dr Kilian Kelly. Discover how Cynata’s Cymerus™ stem cell platform is revolutionising regenerative medicine and get the latest updates on our clinical trials. Date: Thursday 27 June Time: 2pm AEST Don't miss this chance to ask Dr Kelly your questions during the live Q&A. Register here: https://bit.ly/3zcAAJO #webinar #stemcelltherapy #biotech #regenerativemedicine #ASX
Join now to see what you are missing
Similar pages
- Imugene Limited Biotechnology Research Sydney, New South Wales
- Prescient Therapeutics Biotechnology Research South Melbourne, Victoria
- Mesoblast Limited Biotechnology Research Melbourne, VIC
- oNKo-innate Pty Ltd Biotechnology Research Melbourne, VIC
- Cartherics Pty Ltd Biotechnology Research Notting Hill, Victoria
- Chimeric Therapeutics Biotechnology Research Carlton, Victoria
- Paradigm Biopharmaceuticals Pharmaceutical Manufacturing Melbourne, Victoria
- Argenica Therapeutics Pharmaceutical Manufacturing Nedlands, Perth, Western Australia
- Orthocell Ltd Biotechnology Research Perth, Western Australia
- Dimerix Limited Pharmaceutical Manufacturing Melbourne, Victoria
Browse jobs
- Research Assistant jobs 1,347 open jobs
- Data Manager jobs 3,466 open jobs
- President jobs 480 open jobs
- Science Writer jobs 59 open jobs
- Developer jobs 7,182 open jobs
- Account Manager jobs 4,552 open jobs
- Engineer jobs 16,056 open jobs
- Director jobs 35,133 open jobs
- PHP Developer jobs 363 open jobs
- Medical Laboratory Scientist jobs 72 open jobs
- Scientist jobs 706 open jobs
- Management Consultant jobs 5,278 open jobs
- Biochemist jobs 468 open jobs
- Clinical Research Coordinator jobs 313 open jobs
- Medical Science Liaison jobs 58 open jobs
- Clinical Trial Assistant jobs 203 open jobs
- Materials Planner jobs 156 open jobs
- Researcher jobs 6,382 open jobs
- Sales Manager jobs 7,003 open jobs
- Marketing Manager jobs 4,309 open jobs